Deven Choksey is bullish on Alembic Pharmaceutical has recommended buy rating on the stock with a target price of Rs 1,132 in ...

Key opportunities in the U.S. pharmaceutical market include growth in specialty drugs and personalized medicine, driven by ...

Indian pharma’s strong fundamentals signal shift towards higher-margin, science-driven models: Bhavin Mehta: Nandita Vijayasimha, Bengaluru Monday, November 10, 2025, 08:00 Hrs ...

NPPA revokes its earlier direction refusing discontinuation of GSK's antifungal formulation: Gireesh Babu, New Delhi Saturday ...

The Immunosuppressants API market offers significant growth potential driven by increasing prevalence of autoimmune diseases ...

'Vande Mataram' 150th anniversary controversy: What were the original stanzas and why were they cut?

Ahmedabad: Senores Pharma has announced the appointment and categorization of Manohar Lalge, President-Research and Development, as Senior Management Personnel of the Company.Manohar Lalge ...

Formulation sales in India were Rs 4,734.8 crore, registering a growth of 11%. India Formulation sales accounted for 32.9% of ...

Indoco Remedies' consolidated net loss narrowed to Rs 9.21 crore in Q2 FY26, compared with net loss of Rs 10.01 crore reported in Q2 FY25.

Pharma leader Sun Pharmaceutical Industries has recorded a Rs 3,118 crore net profit in Q2 FY26, up 2.56 percent, as India ...

The company’s total revenue from operations in Q2FY26 increased nearly 9% to ₹14,478.31 crore from ₹13,291.39 crore, year-on-year (YoY).